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Blueberry mufﬁn baby is a rare neonatal skin disorder. Causes for the generalized hemorrhagic purpuric
eruptions include congenital infections, hemolysis, and tumors.We report a 2.5-month-old femalebabywith
a blueberrymufﬁn appearance, respiratory distress, anddecreased activity andappetite. Skin biopsy showed
diffuse inﬁltrates of myeloperoxidase- and lysozyme-positive blast-like cells in dermis and superﬁcial
subcutis. Bonemarrow study conﬁrmed the diagnosis of acutemonocytic leukemiawith leukemia cutis. The
skinnodules regressedspontaneouslywithout chemotherapyover several days, and theperipheral bloodcell
counts normalized. This spontaneous remission lasted for 2 months. Spontaneous remission of infantile
leukemia is rare, and its mechanism remains unknown. Although overt leukemia relapsed in some of these
patients, a delay in chemotherapy spared these infants of the toxic effects of treatment.
Copyright  2011, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Leukemia cutis occurs in 25e30% of infants with leukemia,
most commonly with acute myelogenous leukemia of the Frenche
AmericaneBritish (FAB) classiﬁcation M4 or M5.1,2 Skin lesions
typically consist of bluish or purplish dermal nodules in a general-
ized distribution.1e3 The natural history of congenital leukemia is
usually fatal despite aggressive chemotherapy, although a few
patients have experienced temporary or permanent spontaneous
remissions.1 We report an infant with leukemia-associated blue-
berry mufﬁn syndrome, whose clinical course was unusual because
of a temporary spontaneous remission.Case report
A 2.5-month-old baby girl was brought to our hospital with a 7-day
course of multiple bluish skin nodules and a 2-day history of poor
activity, decreased appetite, and respiratory distress. She was born
to a healthy 28-year-old woman after an uncomplicated pregnancy
and had appeared healthy until 1 week ago. Physical examination
revealed a phenotypically normal but ﬂoppy and unconscious
female infant with multiple 0.3- to 3 cm-sized bluish-purpuricogy, Chang Gung Memorial
an.
Hui).
iwanese Dermatological Associatiomacules and subcutaneous nodules on the chest, abdomen, and
back (Figure 1). Laboratory studies revealed a white blood cell
count of 79900/mL with 15% abnormal lymphocytes and mono-
cytes, hemoglobin of 3.5 g/dL, and a platelet count of 50 000/mL.
Skin biopsy under the clinical diagnosis of blueberry mufﬁn
syndrome showed diffuse inﬁltrates of monotonous blast-like cells
with round, vesicular nuclei; granular cytoplasm; andmanymitotic
ﬁgures in dermis and superﬁcial subcutis (Figure 2).
Immunohistochemically, the blast cells were positive for mye-
loperoxidase, lysozyme (Figure 3), CD43, and KP1. CD117, Terminal
deoxynucleotidyl transferase (TDT), tryptase, neuron-speciﬁc
enolase, and synaptophysin were negative. The pathologic diag-
nosis was acutemyeloid leukemia cutis. In the mean time, 41% blast
cells were identiﬁed by peripheral blood smear. Bone marrow
aspiration demonstrated 58.6% blast cells, most of them being large
primitive cells with roughly circular nucleus and abundant baso-
philic cytoplasm.
These blast cells are negative for periodic acideSchiff and
myeloperoxidase stains. They are positive for human leukocyte
antigen (HLA)-DR, CD13, CD14, CD15, CD33, and CD34. Few of
them expressed weakly for CD41. The cellular morphologic ﬁnd-
ings and staining were consistent with acute monocytic leukemia,
FAB classiﬁcation M5. Peripheral blood mutation of GATA 1 wild
type was not detected. The admission course was complicated by
tumor lysis syndrome with hyperkalemia, hypocalcemia, hyper-
phosphatemia, hyperurecemia, and acute renal failure. Supportiven. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Multiple 0.3- to 3-cm-sized bluish and purpuric macules and subcutaneous
nodules on the chest and abdomen.
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general condition. The skin nodules regressed spontaneously
without chemotherapy over several days, and her blood cell counts
gradually normalized. Peripheral blood showed spontaneous
remission without immature blood cells in the subsequent weeks.
The spontaneous remission of leukemia raised the possibility of
Down syndrome. However, there is no characteristic dysmorphic
feature, and cytogenetic study of Down syndrome was not per-
formed at that time.
Twomonths later, a relapse of acute myeloid leukemia occurred
with hepatosplenomegaly, followed by multiple neck and inguinal
lymphadenopathies. No cutaneous nodules were present. Labora-
tory evaluation showed a white blood cell count of 24500/mL with
95.7% lymphocytes, 2.3% atypical lymphocytes, and 2% blast cells;
hemoglobin of 6.6 g/dL; and a platelet count of 77000/mL. Reverse
transcriptase polymerase chain reaction studies of peripheral blood
were positive for mixed-lineage leukemia (MLL)-AF9 fusionFigure 2 (A) Diffuse inﬁltrates in dermis and superﬁcial subcutis. (B) Monotonous blast-l
(hematoxylin and eosin, original magniﬁcation 20 [A] and 400 [B]).transcript [t(9;11)], whereas they were negative for MLL-AF6
[t(6;11)] and MLL-ENL [t(11;19)ENLa1] fusion transcript. These
clinical and laboratory ﬁndings along with MLL rearrangement of
peripheral blood conﬁrmed a relapse of acute myeloid leukemia.
The patient was then enrolled into Taiwan Pediatric Oncology
Group acute myeloid leukemia (AML) 97A protocol because of
progression of disease and the presence of high-risk cytogenetic
feature. She received four courses of chemotherapy with regimens
of idarubicin, cytarabine (Ara-C), high-dose Ara-C (HD-Ara-C), and
Etoposide (VP-16). Unfortunately, she died at 16 months of age
because of Candida meningitis, and further study of Down
syndrome was not performed.Discussion
Blueberry mufﬁn baby is a morphologic term used to describe the-
appearance of non-blanching, blue-redmacules or ﬁrmpapules, and
nodules in young babies.4 The eruption is often generalized but
favors the trunk, head, and neck.4 It had been reported to be
a manifestation of either dermal erythropoiesis or neoplastic inﬁl-
trations.4,5 Dermal erythropoiesis may be caused by congenital virus
infections, such as rubella, cytomegalovirus, coxackie virus B2, and
parvovirus B19, or by severe hemolysis associated with Rh incom-
patibility, blood group incompatibility, hereditary spherocytosis, and
twinetwin transfusion syndrome.4 Among the neoplastic diseases
with the presentation of blueberry mufﬁn babies, neuroblastoma
was the most common, whereas rhabdomyosarcoma, Langerhans
cell histiocytosis, and leukemia were less frequently reported.4,5
A skin biopsy is invaluable in the diagnostic evaluation of
blueberry mufﬁn babies. If dermal collections of nucleated and
nonnucleated red blood cells with a few myeloid precursors are-
seen, further studies to diagnose the causes of dermal erythro-
poiesis should include a peripheral blood cell count, hemoglobin
level, congenital infection (TORCH) serologies, viral cultures, and
Coombs’ test.4 If the histopathologic ﬁndings suggest neoplastic
inﬁltrations, histochemical stainings, immunohistochemicalike cells with round, vesicular nuclei; granular cytoplasm: and many mitotic ﬁgures
Figure 3 The blast cells were positive for (A) myeloperoxidase (original magniﬁcation 400) and (B) lysozyme (original magniﬁcation 400).
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marrow studies, and image studies may help conﬁrm the diagnosis.
The skin nodules and peripheral blasts of our patient regressed
spontaneously over the course of several weeks without chemo-
therapy. Review of the English literature revealed several reports of
infantswith spontaneously remitting leukemia, including four cases
with isolated skin involvement and 15 cases with widespread
diseases.1,5,6 The mechanism of spontaneous remission is not clear.
One of the proposed hypotheses is that the tumor burden is low
enough to be overcome by the patient’s immune system.3,6 Another
explanation corresponds to the “multiple-hit” theory of leukemo-
genesis.3,6 The abnormal leukocytes observed initially may repre-
sent amyeloid clonederived fromamultipotentprogenitor cellwith
enhanced proliferative capacity but are incapable of indeﬁnite self-
renewal and, thus, are not “fully malignant.”3,6 Once the abnormal
leukocytes acquired additional genetic anomalies, a frank leukemia
mayensue.3,6 Trisomy21,11q23, and t(1;22)(p13;q13) translocations
are the most common chromosomal aberrations associated with
neonatal leukemia. These cytogenetic abnormalities found in the
leukemic cells of neonates and infants are clearly different from
those in older children and adults, and this may explain, in part, the
unique biological characteristics of the disease in this age group7,8 Of
the 19 patients who achieved spontaneous remission, relapses of
leukemia have been documented in six patients after a mean of 11.8
months (range: 2e21 months).1 Only one of these patients had iso-
lated leukemia cutis without bone marrow or peripheral blood
involvement, which suggests that patients with widespread disease
at diagnosis might have a higher rate of relapse after spontaneous
remission.1 Close surveillance after spontaneous remission is
important to monitor for evidence of relapse.6
Speciﬁcally, neonatal leukemia occurring in patients with Down
syndrome has been called by a variety of terms, such as transient
myeloproliferative disorder (TMD) and transient leukemia. TMD
has an almost universal association with Down syndrome or other
manifestation of trisomy 21 (including mosaicism in blast cell). It is
crucial to differentiate TMD from congenital leukemia because it
always remits spontaneously in the beginning. In this instance,a delay in chemotherapy spares these infants the toxic effects of
treatment. On the other hand, a spontaneous remission in
congenital leukemia is relatively rare, except the FAB M5 subgroup.
The prognosis of congenital leukemia is generally poor, and an
improvement in the chemotherapy of these patients is needed to
achieve higher sustained remission rate.7,8
Given the widely variable courses of leukemia in young infants,
some authors recommended an initial conservative management
to allow for the possibility of spontaneous remission and reserve
chemotherapy for those with progressive disease or certain high-
risk cytogenetic features that are associated with aggressive clinical
courses, such asMLL (11q23) rearrangement and breakpoint cluster
region (BCR)-c-abl oncogene 1(Abl) [t(9;22)] translocation.1,6 This
“watchful waiting” approach might spare very young infants the
severe morbidity of chemotherapy. Even if a relapse occurs after
spontaneous remission, such a postponement of chemotherapy
allows time for growth and development; hence, the infants are
less vulnerable to the toxic effects of chemotherapeutic agents.3
However, to date, there are no distinguishing features to predict
the occurrence of spontaneous remission at the time of diagnosis.2
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